Herb World News Online

Herb Research Foundation

 Top News  |  World  |  Science  |  Research Reviews  |  Politics  |  Industry  |  Features
 Herb Research Foundation News Archive

Ephedra safety study in progress.

  On June 12, the Ephedra Research Foundation told FDA that acute phase results from industry-sponsored safety research will be available by November 1. As of May 31, 59 of 150 mildly-to-severely overweight subjects had completed the study. All patients were monitored for blood pressure increase, heart rate, and arrhythmia after taking medication containing ephedra alkaloids and caffeine. The foundation requested that FDA "delay the issuance of any final rule or guidance document" on ephedra as a dietary supplement until the agency has reviewed the results of this study. Research is currently under way at Beth Israel-Deaconess Medical Center in Boston and St. Luke's-Roosevelt Hospital in New York City.  
  F-D-C- "The Tan Sheet" July 13, 1998.  
Back to the HRF News Archive Table of Contents
 Top News  |  World  |  Science  |  Research Reviews  |  Politics  |  Industry  |  Features

© 1999 by Herb Research Foundation, Boulder, CO, USA.

Main Page